Log in Register

Login to your account

Username
Password *
Remember Me

Create an account

Fields marked with an asterisk (*) are required.
Name
Username
Password *
Verify password *
Email *
Verify email *
Captcha *

Articles

Details
Published on Wednesday, 22 September 2010 12:50
Hits: 1878

Journal of Clinical Investigation(JCI)

Editorials/Commentaries 2002

Issue
Editorial
Volume 109(1)
1 January 2002
Commentary
(1)Pituitary adenomas in man and mouse:oncogenic potential of a truncated fibrobalst growth factor receptor 4
(2)The buzz about BAFF
Volume 109(2)
15 January 2002
Commentary
(1)Clearing the way to implantation
(2)CD40L in autoimmunity and mucosally induced tolerance
Volume109(3)
1 February 2002
Commentary
(1)Tumor immunotherapy:inching toward the finish line
(2)Putting the neo into neoangiogenesis
Volume109(4)
15 February 2002
Commentary
(1)Proteotoxicity in the endoplasmic reticulum:lessons from the Akita diabetic mouse
(2)Genetic models:clues for understanding the pathognesis of idiopathic nephrotic syndrome
(3)Transcription factor haploinsufficiency:when half a loaf is not enough
Volume109(5)
1 March 2002
Editorial
(1)A Mission Statement for the JCI at the Dawn of the 21st Century
Volume109(6)
15 March 2002
Commentary
(1)What sentisized cells just might be doing in glomerulonephritis
(2)Serial killer:angiotensin drives cardiac hypertrophy via TGF-ß1
(3)A chicken-or-egg conundrum in apoptosis:which comes first?-Ceramide of PKCdelta
(4)Splenic immunity and atherosclerosis:a glimpse into a novel paradigm
Volume109(7)
1 April 2002
Commentary
(1)Controlling the controls:GAD65 autoreactive T cells in type 1 diabetes
Volume 109(8)
15 April 2002
Commentary
(1)The plasma kalleikrein-kinin system conterbalances the renin-angiotensin system
(2)Cheorepulsion and thymocyte emigration
Volume 109(9)
1 May 2002
Commentary
(1)NO solutions?
Volume 109(10)
15 May 2002
Commentary
(1)Leptin:a novel therapeutic role in lipodystrophy
(2)Whence nitrotyrosine?
Volume 109(11)
4 June 2002
Commentary
(1)The thyroid axis just got more complicated
(2)Acina-to-ductal metaplasia in pancreatic cancer development
Volume
109(12)
15 June 2002
Commentary
(1)Optimizing hematopoetic recovery following bone marrow transplantation
(2)Tissue plasminogen activator and seizures:a clot-buster's secret life
(3)TGF-ß antagonists:Why supress a tumor suppressor?
Volume 110;1
1 July 2002
Commentary
(1)Human CYPA1 deficiency:progress and enigmas
(2)The choreography of cyclooxygenases in the kidney
Volume 110;2
15 July 2002
Commentary
(1)The surprising role of vascular K(ATP) cahmmel in vasospastic angina
(2)Regulation of renin expression and blood pressure by Vitamin D3
(3)Making room for T cells
(4)The TSH receptor reveals itself
Volume 110;3
1 August 2002
Commentary
(1)Optimizing hematopoietic stem cell engraftment:a novel role for thrombopoietin
(2)Renal interstial fibrosis:Remembrance of things past?
(3)Maternal-fetal conflict--lessons from transgene
Volume 110;4
15 August 2002
Commentary
(1)The lung as a metabolic factory for gene therapy
(2)Clinical use of TNF revisited:improving penetration of anti-cancer agents by increasing vascular permeability
(3)Malnutrition a frequent misdiagnosis for hemodialysis patients
(4)Home sweet home: how do virus specific T cells navigate to the skin?
Volume 110;5
1 September 2002
Volume 110;6
15 September 2002
Commentary
(1)Hot new therapy for sepsis and acute respiratory distress syndrome
(2)c-Rel deliver a one-two punch in Th1 cell differentiation
(3)Cancer therapy and renal injury
(4)Do NKT cells control autoimmunity?
(5)The plastic fetal pituitary
Volume 110;7
1 October 2002
Commentary
(1)Endothelial integrins and angiogenesis:not so simple anymore
(2)Anxiolytic drug targets:beyond the usual suspects
(3)Antineutrophil cytplasmic antibody and vasculitis:much more than a disease marker
Volume 110;8 
15 October 2002
Commentary
(1)Does loss of bile acid homeostasis make mice melancholy?
(2)Genome-wide responses of a pathogenic bacterium to its host
(3)Defective cardiac ion channels:from mutations to clinical syndromes
(4)Intestinal attraction:CCL25 functions in effector lymphocyte recruitment to the small intestine
Volume 110;9
 1 November 2002
Commentary
(1)SgK: an old enzyme revisited
(2)Dual innervation of white adipose tissue:some evidence for parasympathetic nervous system involvement
(3)Modeling the benefits of pamidronate in children with osteogenesis imperfecta
Volume 110;10
15 December 2002
Commentary
(1)A full complement of receptors in immune complex diseases
(2)Unexpected news in renal fibrosis
(3)Getting peptide vaccines to work: just a matter of quality control?
(4)Calcitonin and bone formation: a knockout full of surprises